drugset / Trial / NCT02346760
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of a single subcutaneous dose of UB-621 in healthy volunteers.
Timeline
- Start
- 2015-12
- Primary completion
- 2017-01
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UB-621 | Monoclonal antibody | 100 mg/ml | Subcutaneous |